Tilray is listed to report before the market opens, with an expected quarterly loss of $0.15 per share and $266 million in sales. These are estimates, not results, and the article gives no comparison to earlier results.
The estimate points to a loss, but the article gives no earlier result or company forecast for comparison. It reports no actual results, so it adds no new evidence about how Tilray's business is doing.
Helen Of Troy is listed with an expected quarterly profit of $0.46 per share and $442 million in sales. The article gives estimates, not actual results or a comparison with earlier results.
Ryde Group is expected to report first-quarter results, but the article gives no figures or actual results. It provides no new information about how the quarter went.
AngioDynamics is listed with an expected quarterly loss of $0.11 per share and $81 million in sales. These are estimates, not results, and there is no comparison with earlier results.
PepsiCo is listed with expected quarterly profit of $2.29 per share and $25 billion in sales. The article gives estimates, not actual results or a comparison with earlier results.
Byrna Technologies is listed with an expected quarterly loss of $0.18 per share and $16 million in sales. These are estimates, not results, and there is no comparison with earlier results.
Follow Tilray Brands (TLRY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TLRY